Abstract

Sepsis induced cardiac dysfunction (SIC) is a severe complication to sepsis which significantly worsens patient outcomes. It is known that bacteria have the capacity to release outer membrane vesicles (OMVs), which are nano-sized bilayered vesicles composed of lipids and proteins, that can induce a fatal inflammatory response. The aim of this study was to determine whether OMVs from a uropathogenic Escherichia coli strain can induce cardiac dysfunction, and to elucidate any mechanisms involved. OMVs induced irregular Ca2+ oscillations with a decreased frequency in cardiomyocytes through recordings of intracellular Ca2+ dynamics. Mice were intraperitoneally injected with bacteria-free OMVs, which resulted in increased concentration of pro-inflammatory cytokine levels in blood. Cytokines were increased in heart lysates, and OMVs could be detected in the heart after OMVs injection. Troponin T was significantly increased in blood, and echocardiography showed increased heart wall thickness as well as increased heart rate. This study shows that E. coli OMVs induce cardiac injury in vitro and in vivo, in the absence of bacteria, and may be a causative microbial signal in SIC. The role of OMVs in clinical disease warrant further studies, as bacterial OMVs in addition to live bacteria may be good therapeutic targets to control sepsis.

Details

Title
Escherichia coli outer membrane vesicles can contribute to sepsis induced cardiac dysfunction
Author
Svennerholm, Kristina 1 ; Park, Kyong-Su 2 ; Wikström, Johannes 3 ; Lässer, Cecilia 2 ; Crescitelli, Rossella 2 ; Shelke, Ganesh V 2 ; Jang, Su Chul 4 ; Suzuki, Shintaro 2 ; Bandeira, Elga 2 ; Olofsson, Charlotta S 5 ; Lötvall, Jan 4 

 Department of anesthesiology and Intensive Care Medicine, Institute of Clinical Science, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden 
 Krefting Research Centre, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden 
 Bioscience, Cardiovascular and Metabolic Diseases, IMED Biotech Unit, AstraZeneca, Mölndal, Sweden 
 Krefting Research Centre, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden; Codiak BioSciences Inc, Cambridge, MA, USA 
 Department of Physiology/Metabolic Physiology, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden 
Pages
1-11
Publication year
2017
Publication date
Dec 2017
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
1983428976
Copyright
© 2017. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.